IMU Imugene Ltd
- 0.039
- +0.002+5.41%
Imugene Ltd News
Imugene Doses First Patient in Intratumoral Injection Group of Phase 1 Cancer Trial
Five at Five AU: ASX to End Week on a High Note | ASX:IMU, OTC:IUGNF
Why Imugene, Neuren, Sigma, and Smartgroup Shares Are Charging Higher
Imugene Opens First Australian Site for Azer-cel Clinical Trial Targeting Lymphoma | ASX:IMU, OTC:IUGNF
Why Core Lithium, Imugene, Lifestyle Communities, and Mineral Resources Shares Are Charging Higher
Guess Which ASX 300 Stock Is Jumping 11% on Big News
Imugene VAXINIA Achieves Complete Response in Patient Two Years After Bile Tract Cancer Treatment
Imugene VAXINIA Achieves Complete Response in Patient Two Years After Bile Tract Cancer Treatment | ASX:IMU, OTC:IUGNF
2 All Ords ASX Healthcare Shares Making BIG Moves on Quarterly Updates
Why AGL, Imugene, Star, and Woolworths Shares Are Dropping Today
Those Who Invested in Imugene (ASX:IMU) Five Years Ago Are up 144%
With Inflation 'Proving Persistent', Is Now Really a Good Time to Buy ASX Tech Shares?
AU Evening Wrap | ASX Surpasses 8200 as Fed Cuts Rates; BHP Rallies on Morgan Stanley Buy Rating
AU Evening Wrap | ASX Hits Record High Despite Slump in Rio Tinto and BHP
Imugene Secures FDA Orphan Drug Designation for Bile Tract Cancer Treatment
Imugene Price Target Cut 33% to A$0.10/Share by Bell Potter
Wall Street Analysts Are Bullish on Top Healthcare Picks
Why Appen, Cettire, DroneShield, and Imugene Shares Are Racing Higher
Stocks of the Hour: Imugene, RocketDNA, Marquee Resources
Why This ASX All Ords Stock Is Soaring 30% on Monday
Analysis
Price Target
No Data
No Data